ProCE Banner Activity

Metabolic Outcomes and 2-Drug Regimens: Insights for Latin America From IDWeek 2021

Conference Coverage
Clinical Thought
There is a need for deeper understanding of how 2-drug regimens and metabolic complications affect Latin American PWH given the need for effective ART that does not worsen obesity in a region where this can be prevalent.

Released: October 28, 2021

Expiration: October 27, 2022

Share

Faculty

Brenda E. Crabtree Ramírez

Brenda E. Crabtree Ramírez, MD

Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Brenda E. Crabtree Ramírez, MD

Assistant Professor, HIV Program
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Mexico City, Mexico

Brenda E. Crabtree Ramirez, MD, has disclosed that she has received consulting fees from Janssen, MSD, and ViiV Healthcare.